Transcriptomic profiling of exRNA from spent human embryonic-cleavage culture medium reveals potential in embryo quality assessment：a retrospective study
In brief
ExRNA profiling of culture fluid predicts embryo viability with over 95% accuracy
In a retrospective analysis of 34 day-3 embryo culture samples, researchers identified a 300-gene exRNA signature that distinguished high- versus low-grade embryos, achieving an area-under-the-curve above 0.95 using a LogitBoost model. The non-invasive test could complement morphology assessment, but larger prospective studies are needed to confirm its clinical utility.
- Journal
- Reproduction (Cambridge, England) (Q1)
- Published
- 13 July 2026
- Study design
- Cohort / observational study
- Evidence level
- Level 4, Very Low (CEBM 4)
- Authors
- Yuxian Feng, Min Pan, Kai Deng, Xinling Cheng, Zeyu Ma, Congying Lin, et al.
- PMID
- 42444146
- DOI
- 10.1093/reprod/xaag086
Why clinicians should know about it
- Picked for Embryology (top studies of the week, 19 July 2026): Transcriptomic profiling of exRNA from spent embryo culture medium
Abstract
The exRNA transcriptome of the preimplantation embryo culture medium constitutes a comprehensive profile of embryonic RNAs, offering a non-invasive resource for elucidating developmental status. To delineate its relationship with the maternal-to-zygotic (MZT) transition and evaluate its predictive potential for developmental outcomes, we performed systematic exRNA transcriptome profiling of individually cultured cleavage-stage embryos. This study included 34 spent culture medium (SECM) samples for day 3 in vitro preimplantation cleavage embryos from 30 patients undergoing IVF/ICSI. 24 morphologically high-grade samples (Grade I, n = 12; Grade II, n = 12) and 10 low grade samples (Grade III, n = 6; abnormal PNs, n = 2; arrested embryos, n = 2) were included. Embryo transfer after the SECM collection was traced for subsequent clinical pregnancy outcome. ExRNA transcriptome from cleavage SECM showed 81.78% concordance with embryonic gene expression profiles. 1,058 differentially expressed exRNA markers were identified across embryo morphological grading groups, revealing MZT-related molecular dynamics prior to blastocyst formation. A 300-gene signature significantly correlated with embryonic developmental potential was established. The accuracy and robustness of the models were validated using clinical samples. The LogitBoost model built on exRNA profile yielded an AUC value above 0.95, indicating encouraging performance for embryo assessment. This study establishes SECM exRNA profiling as a non-invasive method for capturing key molecular events during early embryo development, particularly MZT activation. The identified exRNA biomarkers and machine learning models provide a promising framework for the objective assessment of embryo developmental potential, warranting further validation to overcome the limitations of conventional morphology-based selection in IVF.
Abstract as published, via PubMed.
For healthcare professionals. The summary is generated by AI from the published abstract, and the evidence level is assigned automatically from the study design on the Oxford CEBM hierarchy. Neither is medical advice. Read the full paper before changing practice.